Neuronetics (FRA:NRC) Short Interest


FRA:NRC Neuronetics Inc FRA:NRC
51 GF Score
Price €1.06
GF Value €1.52
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Neuronetics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:NRC vs ZOMDF, RPID, OM: Short Interest Comparison

For the Medical Devices subindustry, Neuronetics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuronetics Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neuronetics's Short Interest distribution charts can be found below:

* The bar in red indicates where Neuronetics's Short Interest falls into.


FRA:NRC
51GF Score
Neuronetics Inc FRA:NRC
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Neuronetics (FRA:NRC) Overvalued in 2026?

Based on GuruFocus' analysis, Neuronetics stock appears to be undervalued. The current stock price of €1.06 is trading 30.6% below its estimated GF Value™ of €1.52. GuruFocus considers Neuronetics to be Possible Value Trap.

Key valuation signals for FRA:NRC:

  • Short Interest:
  • GF Value™: €1.52 vs. price of €1.06 (30.6% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the FRA:NRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuronetics Business Description

Other Exchanges STIM:USA
Address 3222 Phoenixville Pike, Malvern, PA, USA, 19355
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
51GF Score

Get the complete analysis for FRA:NRC

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.06
Price
€1.52
GF Value